Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$144.13 USD
-1.50 (-1.03%)
Updated Aug 7, 2024 03:59 PM ET
After-Market: $144.02 -0.11 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/29/2024
Time: -- |
9/2024 | $1.48 | 0.00% |
Earnings Summary
For their last quarter, Neurocrine Biosciences (NBIX) reported earnings of $0.63 per share, missing the Zacks Consensus Estimate of $1.15 per share. This reflects a negative earnings surprise of 45.22%. Look out for NBIX's next earnings release expected on October 29, 2024. For the next earning release, we expect the company to report earnings of $1.48 per share, reflecting a year-over-year increase of 80.49%.
Earnings History
Price & Consensus
Zacks News for NBIX
Compared to Estimates, Neurocrine (NBIX) Q2 Earnings: A Look at Key Metrics
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services